However, the combination of MYR-p110α with a CDK4 activating mutation (R24C) led to increased tumorigenesis, demonstrating the interaction between the CDK4/Rb/E2F cascade and the PI3K signalling pathway observed in many human cancers [31]. The gene discussed is CDK4; the disease is cancer.